{
    "root": "36370268-ebc0-8ab1-e063-6394a90adc9e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Icosapent Ethyl",
    "value": "20250528",
    "ingredients": [
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "DIMETHICONE, UNSPECIFIED",
            "code": "92RU3N3Y1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11074"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "TOCOPHEROL",
            "code": "R0ZB2556P8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_27013"
        },
        {
            "name": "ICOSAPENT ETHYL",
            "code": "6GC8A4PAYH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_62801"
        }
    ],
    "indications": {
        "text": "icosapent ethyl capsules indicated : adjunct diet reduce triglyceride ( tg ) levels adult patients severe ( \u2265500 mg/dl ) hypertriglyceridemia . limitations : effect icosapent ethyl capsules risk pancreatitis patients severe hypertriglyceridemia determined .",
        "doid_entities": [
            {
                "text": "pancreatitis (DOID:4989)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4989"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe hypertriglyceridemia determined",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_181425"
            }
        ]
    },
    "contraindications": {
        "text": "assess lipid levels initiating therapy . identify causes high triglyceride levels manage appropriate . ( 2.1 ) patients engage appropriate nutritional intake physical activity receiving icosapent ethyl capsules , continue treatment . ( 2.1 ) daily dose icosapent ethyl capsules 4 grams per day taken two 1 gram capsules twice daily food . ( 2 . 2 ) advise patients swallow capsules whole . break open , crush , dissolve , chew icosapent ethyl capsules . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "icosapent ethyl capsules supplied 1 gram oblong , natural colored transparent soft gelatin capsules logo \u201c a1000 \u201d printed white ink . bottles 120 : ndc 60429-005-12 .",
    "adverseReactions": "icosapent ethyl capsules contraindicated patients known hypersensitivity ( e.g . , anaphylactic reaction ) icosapent ethyl components .",
    "indications_original": "Icosapent ethyl capsules are indicated:\n                  \n                     as an adjunct to diet to reduce\u00a0triglyceride (TG)\u00a0levels in adult patients with severe (\u2265500 mg/dL)\u00a0hypertriglyceridemia.\n                  \n                  \n                     Limitations of Use:\n                  \n                  The effect of\u00a0icosapent ethyl capsules on the risk for\u00a0pancreatitis in patients with severe hypertriglyceridemia\u00a0has\u00a0not been determined.",
    "contraindications_original": "Assess lipid levels before initiating therapy. Identify other causes of high triglyceride levels and manage as appropriate. (2.1) Patients should engage in appropriate nutritional intake and physical activity before receiving icosapent ethyl capsules, which should continue during treatment. (2.1) The daily dose of icosapent ethyl capsules is 4 grams per day taken as two 1\u00a0gram capsules twice daily with food. ( 2 .2) Advise patients\u00a0to\u00a0swallow\u00a0capsules\u00a0whole.\u00a0Do\u00a0not break\u00a0open,\u00a0crush,\u00a0dissolve,\u00a0or chew icosapent ethyl capsules.\u00a0( 2.2 )",
    "warningsAndPrecautions_original": "Icosapent ethyl capsules are supplied as 1 gram oblong, natural colored transparent soft gelatin capsules with the logo \u201cA1000\u201d printed in white ink.\n                  Bottles of 120: NDC 60429-005-12.",
    "adverseReactions_original": "Icosapent ethyl capsules are contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to icosapent ethyl or any of its components.",
    "drug": [
        {
            "name": "Icosapent Ethyl",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_62801"
        }
    ]
}